Adding capivasertib to abiraterone leads to a “clinically meaningful improvement” in OS compared to placebo in patients with PTEN-deficient mHSPC.

The Lazarex Cancer Foundation, which was funded through private philanthropy and industry support, reimbursed qualifying patients for their nonmedical costs at any US trial site from 2006 to 2024.

Researchers evaluated the creation, validation, and user readability of a structured patient education booklet designed to improve disease understanding and health literacy for patients with ovarian ...

Reduction seen following implementation of WISeR program encouraging AI use within prior authorization process ...

In patients with solid cancers, discrepancies in how kidney glomerular filtration rate is assessed will affect their chemotherapy eligibility and dose adjustment.

Once-daily paltusotine reduces both the frequency and severity of carcinoid syndrome symptoms, investigators reported at ...

An ad hoc analysis from the KEYNOTE-905/EV-303 study showed greater improvements in survival outcomes and response rates in ...

Liver transplantation is linked to durable survival for patients with neuroendocrine liver metastases, but careful patient ...